Micro RNA 146a gene variant / TNF-α / IL-6 / IL-1 β; A cross-link axis inbetween oxidative stress, endothelial dysfunction and neuro-inflammation in acute ischemic stroke and chronic schizophrenic patients

https://doi.org/10.1016/j.abb.2019.108193Get rights and content

Highlights

  • CG and GG hsa-miR-146a genotypes were associated with increased risk of schizophrenia and AIS in schizophrenic patients.

  • CG and GG hsa-miR-146a genotypes were significantly associated with thrombomodulin decrement levels and PANSS scores.

  • Also, they were significantly associated with TNF-α, IL-6, IL-1 β, PAI-1, and 8-OHdG increment.

  • Oxidative stress and DNA damage as a result of the neuro-inflammatory status originated from the hsa-miR-146a C>G gene SNP.

  • This confirms their role in the pathogenesis of schizophrenia and its associated AIS risk.

Abstract

This work was purposed to speculate the possible association of rs2910164hsa-miR-146a C>G gene single nucleotide polymorphism in the pathogenesis of schizophrenia and subsequently their relevance to neuro-inflammatory, vascular and oxidative stress pathways as acute ischemic stroke (AIS) risk factors in chronic schizophrenic patients. 450 subjects, 150 healthy controls (group I), 150 chronic schizophrenic patients without any evidences of stroke (group II) and 150 chronic schizophrenic patients with AIS (group III) were included. Genotypes (CC, CG&GG) for hsa-mir-146a gene polymorphism were identified using polymerase chain reaction-restriction fragment length polymorphism PCR-RFLP technique. Tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), interleukin 1β (IL-1 β), plasminogen activator-inhibitor 1 (PAI-1), thrombomodulin (TM) and 8-Hydroxy-2-deoxyguanosine (8-OHdG) serum levels were immunoassayed. Complete lipid profile was estimated. The CG and GG hsa-miR-146a genotypes were associated with increased risk of both schizophrenia and AIS in schizophrenic patients with thrombomodulin levels decrement in group II& III. On the other side, the risk genotypes were associated significantly with positive and negative syndrome scale PANSS scores, TNF-α, IL-6, IL-1 β, PAI-1, and 8-OHdG increment levels in both groups II & III. By contrast, the CG and GG hsa-miR-146a genotypes did not affect the neuro-inflammatory and oxidative stress markers in healthy controls. These findings illustrate a new mechanism strengthening the occurrence of oxidative stress and DNA damage as a result of the neuro-inflammatory and endothelial dysfunction status originated from the hsa-miR-146a C>G gene single nucleotide polymorphism, thus, confirming their role in the pathogenesis of schizophrenia and its AIS risk.

Introduction

Schizophrenia is a chronic crushing mental disorder that is presented mainly by positive, negative and cognitive symptoms [1,2]. Its clinical course is usually characterized by recurrent relapses that cause an additional burden on cognitive performance, treatment response, and psychosocial functions [3]. The chronicity of schizophrenia and its drug-resistant course may also favor some neurodegenerative processes, although the proof of neuronal death in schizophrenia is highly controversial [4]. Chronic schizophrenic patients were approved to have two to three times' higher risk of premature death than general population, with life expectancy decrement of 15–20 years. Basically, acute ischemic stroke (AIS) includes brain blood flow obstruction with irreversible brain damage, is considered one of the main causative leading agents of schizophrenic patients premature death [5]. Despite the great controversy in schizophrenia pathogenesis and its role in AIS incidence, few studies have established an association between environmental-genetic deregulations, neuro-inflammation, thrombosis, oxidative stress and this illness [6]. The principal underlying cause of AIS is vascular thromboembolic occlusion [7]. Importantly, endothelial-generated anti- and pro-coagulant residues are un-equivalently distributed throughout the vascular bed. Endothelial cells exerts an anticoagulant activity by expressing tissue factor pathway inhibitor, like thrombomodulin (TM) which binds thrombin and promotes protein C and thrombin activated fibrinolysis inhibitor (TAFI) segmentation, thereby obstacles coagulation and inducing fibrinolysis [8]. Even though, endothelial cells also show a procoagulant activity, as it manufactures plasminogen activator inhibitor (PAI-1), the main physiological inhibitor of tissue plasminogen activator (tPA) [9]. PAI-1 causes inactivation of urokinase plasminogen activator (uPA) that regulates the production of plasmin [10]. In addition, increased levels of PAI-1 have been recognized as a hallmark of endothelial dysfunction [11]. Bleeding or hypercoagulability and thrombosis may occur as a result of acquired alterations in the dynamic balance in vascular pathophysiology [12]. MicroRNAs (miRNAs) are one of the main eukaryotic genetic modulators that have been approved to be responsible for regulation of many cellular pathways. Alteration in circulating miRNAs levels has been documented to be intimately associated with incidence of many different human diseases, such as type 2 diabetes, cerebral stroke, neuropsychiatric disorders and immunological diseases [[13], [14], [15]]. Recently, hsa-miR-146a was identified as a potential diagnostic biomarker in various diseases with its gene located on the long arm of chromosome 5 (5q 33.3) with about 109 bases length (via NCBI) [16]. Cytokines are immune/inflammatory protein modulators that act as chemical messengers between immune cells modify the neurotransmitters and neuro-endocrine hormones metabolism, thus affecting neural development and behavioral changes [17]. Interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α are a group of proinflammatory cytokines which have been indulged as a cardinal axis of a common pathway of AIS incidence and schizophrenia liability factors. Its production and signaling are intimately regulated by a various genes that may be accused for schizophrenia [18]. Oxidative stress has hazardous damaging effects on different cellular components and causes DNA damage with subsequent formation of 8-hydroxy-2' -deoxyguanosine (8-OHdG) that has been largely used as a biomarker for oxidative stress DNA damage [19]. This study was undertaken to investigate the possible contribution of rs2910164 hsa-miR-146a C>G gene single nucleotide polymorphism to the molecular pathogenesis of schizophrenia and highlights their relation with neuro-inflammatory, endothelial dysfunction and oxidative stress pathways as AIS risk factors in patients with chronic schizophrenia.

Section snippets

Subjects

This prospective cross-sectional study was carried out in the Medical Biochemistry and Neuropsychiatry Departments, Faculty of Medicine, Tanta University. This study was conducted on 450 adult males aged 45–60 years. Uncooperative participants and those with hypertension, diabetes mellitus, renal diseases, malignancy, adrenal diseases, liver dysfunction, allergy, lipid or carbohydrate metabolic inborn disorders, peripheral vascular disease, cardiac dysfunction, head injuries history, recent

Results

Clinical and demographic characteristics of the studied groups: are shown in Table 1. No statistically significant difference was detected between the studied groups regarding age, number of hospitalization, duration of schizophrenia by years and BMI. The history of diabetes type 2, hypertension and smoking are significantly different across groups and particularly high in SZ with AIS. The lipid profile, carotid intima media thickness (cIMT) and atherogenic index (AI) were statistically

Discussion

In the present study, we initially compared the distribution of rs2910164 hsa miR-146aSNP between Egyptian schizophrenic patients with and without AIS and healthy controls to investigate a potential association of this mir-146a SNP with both schizophrenia and AIS susceptibility in those patients. Our preliminary data revealed increased frequencies (%) of the variant genotypes (CG+GG) in schizophrenic patients with AIS compared to schizophrenic patients without AIS and controls. Concomitantly,

Funding

This research did not receive any specific grant from funding agencies in the public, Commercial or not for profit sectors.

Declaration of competing interest

The authors declare that they have no conflict of interests.

Acknowledgment

We would like to acknowledge Dr. Rasha Lotfy, Radiology Department, Faculty of Medicine, Tanta University, for her valuable help in the Doppler Ultrasonography, Carotid intima media thickness (cIMT), computed tomography (CT) scan and Echocardiograph (ECG) that were done to all patients evaluation in the present work.

References (49)

  • W. Lu et al.

    Trafficking of Α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA) receptor subunit GluA2 from the endoplasmic reticulum is stimulated by a complex containing Ca2+/calmodulin-activated kinase II (CaMKII) and PICK1 protein and by release of Ca2+ from internal stores

    J. Biol. Chem.

    (2014)
  • G. Anderson

    Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination

    Med. Hypotheses

    (2011)
  • G. Anderson et al.

    Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2013)
  • E.M. Elbaz et al.

    Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κBsignalling pathway modulation

    Toxicol. Appl. Pharmacol.

    (2018)
  • P. De Cesaris et al.

    Tumor necrosis factor-alpha induces interleukin-6 production and integrin ligand expression by distinct transduction pathways

    J. Biol. Chem.

    (1998)
  • N. Stickel et al.

    MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD

    Blood

    (2014)
  • S.R. Lentz et al.

    Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms

    Blood

    (1991)
  • L.C. Monteiro et al.

    Insight, cognitive dysfunction and symptomatology in schizophrenia

    Eur. Arch. Psychiatry Clin. Neurosci.

    (2008)
  • Y. Noda et al.

    Evaluation of short interval cortical inhibition and intracortical facilitation from the dorsolateral prefrontal cortex in patients with schizophrenia

    Sci. Rep.

    (2017)
  • Y.K. Kim et al.

    Neuroprotection in schizophrenia and its therapeutic implications

    Psychiatr. Invest.

    (2017)
  • J. Wenzel et al.

    Thrombomodulin--a new target for treating stroke at the crossroad of coagulation and inflammation

    Curr. Med. Chem.

    (2014)
  • S. Hoirisch-Clapauch et al.

    Multiple roles of tissue plasminogen activator in schizophrenia pathophysiology

    Semin. Thromb. Hemost.

    (2013)
  • R. Jin et al.

    Role of inflammation and its mediators in acute ischemic stroke

    J. Cardiovasc. Transl. Res.

    (2013)
  • C. Ince et al.

    The endothelium in sepsis

    Shock

    (2016)
  • Cited by (26)

    • miR-146a and miR-200b alter cognition by targeting NMDA receptor subunits

      2022, iScience
      Citation Excerpt :

      In our previous study, we found miR-129-2, miR-148a, and miR-296 to be targeting NMDAR in vitro and in animal models in which NMDAR is dysregulated.16 In this study, we have investigated whether miR-146a and miR-200b, which are differentially expressed in diseases such as Alzheimer's disease and schizophrenia,17,18,19,20,21,22,23,24,25,26,27 can regulate NMDAR subunits. We established the interaction of these miRNAs with NMDAR subunits through online bioinformatic analysis followed by experimental approach using luciferase assay.

    • Changes and roles of IL-17A, VEGF-A and TNF-α in patients with cerebral infarction during the acute phase and early stage of recovery

      2022, Clinical Biochemistry
      Citation Excerpt :

      The high expression of VEGF-A after cerebral infarction may be an important mechanism through which the body counteracts cerebral ischaemia, reduces brain injury, and promotes nerve repair [36,37]. Combined with earlier findings, our results suggest that TNF-α plays a complex role for a long time after cerebral infarction [8,38,39]. Elevated levels of serum IL-17A, VEGF-A and TNF-α can also be observed in several other diseases, such as myocardial infarction and various infections.

    View all citing articles on Scopus
    View full text